donation
To request Mental Health
Services or to access Mental
Health Crisis Services Call:
1-800-375-4357

Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Biden Administration Withdraws Vaccine Mandate for Large EmployersFree N95 Masks Begin Arriving in U.S. PharmaciesEngland to Lift Travel Restrictions for Vaccinated VisitorsMany Marijuana Vendors Aim Advertising at Kids: StudyConservatorships Keep the Homeless in Psychiatric Wards Too Long: StudyCrowded Emergency Rooms Cost Lives: StudyColonoscopy Surprise Bills Should Be Thing of the Past, Experts SayBiden Plans to Send 400 Million N95 Masks to Americans for FreeWhite House Launches Website for Free Home COVID Tests One Day Ahead of SchedulePolitics Clouds Folks' Views on COVID Rules, Global Survey ConfirmsCOVAX Program Has Now Sent 1 Billion COVID Vaccines to Poorer NationsAmid U.S. Blood Shortage, New Pressure to Ease Donor Rules for Gay MenSupreme Court Blocks Biden's Vaccine Mandate for Large EmployersWhite House May Soon Offer 'High-Quality' Masks to AmericansAmericans Should Avoid Travel to Canada: CDCRed Cross Says U.S. Blood Supply at Dangerously Low Level'Secondhand Vaping' May Be Unhealthy — Could Public Bans Be Coming?Many Doctors Uninformed on Rights of Disabled PatientsAmid COVID Test Shortages, Price Gouging Is on the RiseSupreme Court Hears Arguments on Biden's Vaccine Mandate for Big BusinessMore Evidence That State Lotteries Didn't Boost Vaccination RatesWhite House Finalizes Plan to Send Americans Free COVID Rapid TestsMembers of Biden’s Transition Team Call for New COVID PlanDirty City Air Killed More Than 1.8 Million People Globally in 2019Telemedicine as Good as In-Person for Many Health Conditions: ReviewPrison Time Shortens Life Spans for Black Americans, But Not WhitesHeat Waves Bring Health Crises to the HomelessBiden Outlines Measures to Fight Omicron, Pleads With Americans to Get VaccinatedProctor & Gamble Recalls Pantene, Herbal Essences Products Due to BenzeneEarly CDC COVID Tests Were Not Only Contaminated, But Flawed: ReportMany Home Health Care Workers in Poor Health ThemselvesPoor Outcome More Likely When Patient Is Female, Surgeon Is Male: StudyMonths After New Rule, More Than Half of U.S. Hospitals Still Don't Disclose Prices OnlineReport Finds World Ill-Prepared for Next PandemicU.S. to Pump $400 Million Into Vaccination Programs for Other CountriesOver 234,000 Pounds of Ham, Pepperoni Recalled Due to ListeriaCOVID Vaccine, Testing Demand Overwhelming PharmaciesAlmost 13 Million Americans Per Year Skip Meds Due to CostAssistance Dogs Bring Big Boost to Deaf PeopleCDC to Toughen COVID Testing for International TravelersOld Spice, Secret Antiperspirants Recalled Due to BenzeneClinical Trials Are Becoming More Diverse, But There's Still Work To DoRural Hospitals' ERs Just as Effective as Urban Ones: StudyKraft Recalls Powdered Drinks Over Metal, Glass ConcernsVials Found in Lab Contained Vaccine, not Smallpox Virus: CDCAdvances in Care, Impact of COVID Highlights of Latest Cardiologists' MeetingAcross America, Black People Have Worse Health OutcomesVials With Smallpox Labels Found at Vaccine Lab in Pennsylvania: CDCWhite House to Spend Billions to Boost COVID Vaccine SupplyAHA News: Health Class May Influence Heart Risk in South Asians
Questions and AnswersLinksBook Reviews
Related Topics

Health Insurance
Healthcare

More Than 2 Million COVID Home Test Kits Recalled Due to False Positive Results

HealthDay News
by Robert Preidt
Updated: Nov 11th 2021

new article illustration

THURSDAY, Nov. 11, 2021 (HealthDay News) -- A recall of Ellume at-home COVID-19 test kits has been expanded to include roughly 2 million of the 3.5 million tests that had been shipped to the United States by last month, the U.S. Food and Drug Administration said Tuesday.

The original recall, involving 427,000 kits, was first announced in early October due to a "higher than acceptable" rate of false positives. It's a Class I recall — the most serious type — because use of these tests may cause serious adverse health consequences or death, according to the FDA.

The recalled kits were made by the Australian company between Feb. 24 and Aug. 11, 2021, and distributed in the United States between April 13 and Aug. 26.

The FDA first approved emergency use of the test in December 2020 and revised its emergency use last February. The Ellume test is available without a prescription to people with or without symptoms.

There have been 35 reports of false positive results sent to the FDA, but no deaths have been reported, according to the agency.

"Ellume has investigated the issue, identified the root cause, implemented additional controls, and we are already producing and shipping new product to the U.S.," a company representative said, The New York Times reported. "Importantly, not all of the positive results of the affected tests were false positives, and negative results were not affected by this issue."

A false positive test result shows that a person has the virus when they do not have it, which could pose a number of risks, including:

  • Delayed diagnosis or treatment for the actual cause of the person's illness, which could be another life-threatening disease that is not COVID-19.
  • Further spread of the coronavirus when people who are believed to be positive are housed together based on false test results.
  • Unnecessary COVID-19 treatment — such as antiviral treatment, convalescent plasma, or monoclonal antibody treatment — which can cause side effects.
  • Ignoring recommended precautions against COVID-19, including vaccination.
  • Isolation, including monitoring household or close contacts for symptoms, limiting contact with family or friends, and missing school or work.

There is no problem with the reliability of the kits' negative test results, the FDA noted.

Customers with Ellume COVID-19 home test kits should compare the product lot number on the sticker on the side of the carton with the recalled lot numbers. Ellume will inform customers who used an affected test and received a positive result.

The FDA said you should contact your health care provider, urgent care facility or other COVID-19 testing site if you received a positive test result using one of the recalled lots of the Ellume COVID-19 Home Test more than two weeks ago, and if you did not receive a positive result from a different COVID-19 test at the time of the original Ellume positive test result.

A health care provider can help you decide what next steps you should take, the FDA advised.

The agency also said that if you used a test kit from the recalled lots you should not assume that you had COVID-19 or have immunity to COVID-19, and should continue to take recommended precautions, including vaccination.

More information

Here's where to find Ellume's recall notice.

SOURCES: U.S. Food and Drug Administration, news release, Nov. 9, 2021; The New York Times